EI
OKYO

EFG International’s OKYO Pharma OKYO Stock Holding History

EFG International’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49K Hold
923
– – ﹤0.01% 1013
2025
Q4 		$1.91K Buy
+923
New +$2K ﹤0.01% 849

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

EFG International's OKYO Position: Q1 2026 in Review

EFG International held its OKYO Pharma (OKYO) position steady in Q1 2026 at 923 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

EFG International first reported a position in OKYO in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.91K in Q4 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • EFG International held 923 shares of OKYO Pharma worth $1.49K as of Q1 2026.
  • EFG International left its OKYO Pharma share count unchanged in Q1 2026.
  • OKYO Pharma made up ﹤0.01% of EFG International's portfolio in Q1 2026, its #1013 holding.
  • EFG International first reported a position in OKYO Pharma in Q4 2025 and has held it in 2 quarters since.
  • EFG International's OKYO Pharma position peaked at $1.91K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.